Transgender breast cancer care

The color pink has become ubiquitous with the fight against breast cancer, raising awareness for the most deadly nonskin cancer for females in the United States. Breast Cancer Awareness Month (BCAM) activities are important to encourage screenings and tell the stories of patients who have battled breast cancer, but Annie Brown, MD, said the abundance of pink might make people […]

Read more

Fears breast cancer progress could stall due to COVID-19 backlog

Around 10,600 fewer breast cancer patients have started treatment in the last year in England. Breast cancer deaths reached an all-time low before the pandemic, but experts fear these new stats show that this hard-won progress could slow. The charity estimates around 38,000 fewer people started treatment for all cancer types in England. And breast cancer represents more than a […]

Read more

FDA Approves Trodelvy, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival

FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 7, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to Trodelvy® (sacituzumab govitecan-hziy) for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease. The approval is supported by data […]

Read more

Alternative cancer cell fuel source targeted as therapeutic approach for breast cancer

Scientists at The Wistar Institute characterized an inhibitor that targets acetate metabolism in cancer cells. Cancer cells use acetate metabolism to support tumor growth in conditions of low nutrient and oxygen availability. This molecule caused tumor growth inhibition and regression in preclinical studies, demonstrating the promise of this approach as a novel therapeutic strategy for solid tumors. Study results were […]

Read more

Statins may protect the heart from chemotherapy treatment of early breast cancer

Statins, common cholesterol-lowering medications, may protect women’s hearts from damage caused during chemotherapy for early-stage breast cancer, according to new research published today in the Journal of the American Heart Association. “Two types of cancer medications, anthracyclines and trastuzumab, are effective treatments for many women with breast cancer, however, the risk of heart muscle damage has limited their use, particularly […]

Read more

SABCS: Some Older Women With Breast Cancer May Opt to Skip RT

MONDAY, Dec. 14, 2020 — The omission of radiotherapy (RT) does not affect overall survival at 10 years after breast conserving surgery (BCS) for older women with hormone receptor-positive breast cancer, according to a study presented at the annual San Antonio Breast Cancer Symposium, held virtually from Dec. 8 to 11. Ian H. Kunkler, from the University of Edinburgh in […]

Read more
1 2 3 6